- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06166212
Changes in Angle Kappa and Corneal Back Elevations After Laser in Situ Keratomileusis in Myopic Astigmatism
December 3, 2023 updated by: Mohamed Elsaiid, Ain Shams University
Refractive errors and corneal astigmatism are associated with changes in angle kappa and corneal back elevation at the thinnest point in Pentacam.
The purpose of this study is to track:
The effect of anterior corneal astigmatism treatment on angle kappa and corneal back elevation.
Study Overview
Status
Not yet recruiting
Conditions
Detailed Description
This prospective observational study will be settled in Ain Shams University Hospital, Cairo, Egypt.
Study Type
Observational
Enrollment (Estimated)
50
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Mohamed Elsaiid
- Phone Number: 00201028518999
- Email: drmohammed1244@gmail.com
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
N/A
Sampling Method
Non-Probability Sample
Study Population
2 groups
Description
Inclusion Criteria:
Myopic astigmatism
Exclusion Criteria:
Corneal scar
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Cases with high myopic astigmatism
Cases having myopic astigmatism more than 1.5 diopter
|
|
Cases with not high astigmatism
Cases having astigmatism less than 1.5 diopter
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Track changes in angle kappa
Time Frame: through study completion, an average of 2 years
|
Track changes in angle kappa with changes in corneal astigmatism
|
through study completion, an average of 2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
January 1, 2024
Primary Completion (Estimated)
June 1, 2025
Study Completion (Estimated)
November 1, 2025
Study Registration Dates
First Submitted
November 19, 2023
First Submitted That Met QC Criteria
December 3, 2023
First Posted (Estimated)
December 12, 2023
Study Record Updates
Last Update Posted (Estimated)
December 12, 2023
Last Update Submitted That Met QC Criteria
December 3, 2023
Last Verified
December 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- angle K relation e astigmatism
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.